Skip to main content

Idexx Laboratories Inc. Value Stock - Dividend - Research Selection

Idexx

ISIN: US45168D1046 , WKN: 888210

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. It also offers diagnostic and health-monitoring products for livestock, poultry, and dairy markets; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Tracking Ron Baron's BAMCO Portfolio - Q2 2025 Update

2025-09-15
Ron Baron's BAMCO Inc. 13F portfolio grew to $36.89B in Q2 2025. Check out the top holdings and significant stake increases of the portfolio here.

These Were the 3 Top-Performing Stocks in the Nasdaq-100 in August 2025

2025-09-12
The month of August was unremarkable for your average Nasdaq-100 stock -- with a few notable exceptions. These three stocks enjoyed more than 20% price gains in an otherwise sleepy 30-day period.

Should You Add IDEXX Stock to Your Portfolio Right Now?

2025-09-12
IDXX shows strong CAG Diagnostics growth, cloud software momentum and global expansion but faces solvency and macro risks.

IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors despite daily gains

2025-09-11
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors despite daily gains

Is Climb Bio, Inc. (CLYM) Stock Outpacing Its Medical Peers This Year?

2025-09-11
Here is how Climb Bio, Inc. (CLYM) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year.

IDEXX Laboratories Stock: Is IDXX Outperforming the Healthcare Sector?

2025-09-10
Although IDEXX Laboratories has outperformed the healthcare sector over the past year, analysts remain cautiously optimistic about the stock’s prospects.

IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors

2025-09-10
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors

IDEXX Laboratories, Inc. (IDXX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

2025-09-09
Discover IDEXX Laboratories’ innovation-driven growth strategy, robust diagnostic pipeline

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day

2025-09-08
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day

Canine Cancer Screening Market Report 2025: IDEXX Laboratories, Zoetis, and Heska Corporation Lead this Rapidly Evolving Industry

2025-09-08
The key market opportunities in canine oncology diagnostics lie in adopting advanced molecular biology and imaging technologies for early cancer detection. Collaborative innovations in reagents and imaging, next-gen sequencing, liquid biopsies, and AI are reshaping precision care. Tariff adjustments prompt supply chain diversification, while strategic partnerships and vertical integration enhance value delivery. Additionally, a keen focus on regional dynamics, tailored service models, and regula